PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.
about
The Novel PKCθ from Benchtop to ClinicAmeliorated ConA-induced hepatitis in the absence of PKC-thetaAutoimmunity in primary T-cell immunodeficiencies.PKC theta ablation improves healing in a mouse model of muscular dystrophy.Nuclear calcium is required for human T cell activation.Protein kinase C theta is required for efficient induction of IL-10-secreting T cells.4-Hydroxy-17-methylincisterol from Agaricus blazei Decreased Cytokine Production and Cell Proliferation in Human Peripheral Blood Mononuclear Cells via Inhibition of NF-AT and NF-κB Activation.Swiprosin-1 Expression Is Up-Regulated through Protein Kinase C-θ and NF-κB Pathway in T CellsKnockout mouse models of insulin signaling: Relevance past and futurePKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.Protein kinase C-θ promotes Th17 differentiation via upregulation of Stat3.Intervention of PKC-θ as an immunosuppressive regimen.Intracellular Delivery of Anti-pPKCθ (Thr538) via Protein Transduction Domain Mimics for Immunomodulation.
P2860
Q27024068-FA2B97D1-FFEF-41FC-AE03-FC9461EFCED9Q28480548-CEF92961-19F7-4082-9721-441609375955Q30251616-16A57B1F-2051-44A2-9241-4975DC3D52FDQ34163572-AECA7931-5B47-49BB-A3FB-41016E2E3DFCQ34544029-F82D0A6B-793E-4C78-8A6E-F5D11290EB5FQ36269823-81444659-3E60-4FA7-8174-919024FA7D9FQ36692020-95C64B43-6B04-499B-A9BD-FB92B7C699C4Q36859933-D12F7849-D854-46B0-8A84-4BACF656BB62Q38205763-875DE87E-C645-49C5-9302-67447F4999D1Q41140315-0307FEC5-BA20-4DB5-BBE5-2BA6FE7C7AC7Q41613948-4DAD5776-4EE2-4D18-852C-C0CD325C9CB5Q41890374-0A8FB698-9FF1-481F-8431-8A5F75156192Q46029282-E4DE25B7-67A6-4F82-B80A-941584EC9D0D
P2860
PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PKC-θ is a drug target for pre ...... unity and allograft rejection.
@en
PKC-θ is a drug target for pre ...... unity and allograft rejection.
@nl
type
label
PKC-θ is a drug target for pre ...... unity and allograft rejection.
@en
PKC-θ is a drug target for pre ...... unity and allograft rejection.
@nl
prefLabel
PKC-θ is a drug target for pre ...... unity and allograft rejection.
@en
PKC-θ is a drug target for pre ...... unity and allograft rejection.
@nl
P2093
P2860
P1476
PKC-θ is a drug target for pre ...... unity and allograft rejection.
@en
P2093
Myung-Ja Kwon
Ruiqing Wang
Zuoming Sun
P2860
P304
P356
10.2174/1871530311006040367
P577
2010-12-01T00:00:00Z